Results of docetaxel plus oxaliplatin (DOCOX) ± cetuximab in patients with metastatic gastric and/or gastroesophageal junction adenocarcinoma: Results of a randomised Phase 2 study

Donald Richards, Darren M. Kocs, Alexander I. Spira, A. David McCollum, Sami Diab, Lanny I. Hecker, Allen Cohn, Feng Zhan, Lina Asmar

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Results of docetaxel plus oxaliplatin (DOCOX) ± cetuximab in patients with metastatic gastric and/or gastroesophageal junction adenocarcinoma: Results of a randomised Phase 2 study'. Together they form a unique fingerprint.

Medicine & Life Sciences